<DOC>
	<DOC>NCT00271687</DOC>
	<brief_summary>This study aims to provide preliminary data on the feasibility and outcomes of a 12 week exercise program on the quality of life of men with hormone refractory prostate cancer receiving docetaxel-based chemotherapy.</brief_summary>
	<brief_title>A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<criteria>diagnosis of prostate cancer receiving docetaxelbased chemotherapy at the CCI age 18 years or over approval of oncologist informed written consent life expectancy less than 6 months Karnofsky performance score less than 70 contraindications for exercise (e.g. uncontrolled cardiac, respiratory, hypertensive or psychiatric disorder) unable to understand, read, write and speak English unable or unwilling to attend supervised exercise sessions 3 times weekly unable or unwilling to complete outcome assessments</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>exercise</keyword>
	<keyword>exercise therapy</keyword>
	<keyword>activities of daily living</keyword>
	<keyword>quality of life</keyword>
</DOC>